マーケットレポート詳細
医薬品用ゼラチンの世界市場：2027年に至る原料別、用途別予測
Pharmaceutical Gelatin Market by Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry), Application (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat), Function (Stabilizing, Thickening, Gelling), Region - Global Forecast to 2027
- 出版元：MarketsandMarkets
出版元について - 発行年：2022年12月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文190ページになります。
- 商品コード：MAM3134
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
医薬品用ゼラチンの世界市場規模は2022年で11億ドル、2027年に15億ドル、市場の平均年成長率は5.5%に到達する見込みです。
レポートは医薬品用ゼラチンの世界市場について2027年までの市場予測データ(金額US$、量ベースKT)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（用途別市場、タイプ別市場、等）を中心に構成されています。また競合状況、主要企業情報（25社）、エコシステム分析、市場シェア分析などの分析も加味し、医薬品用ゼラチン市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆医薬品用ゼラチンの世界市場予測2020-2027年
・市場規模(US$)
◆用途別、市場-2027 年
・ハードカプセル
・ソフトジェルカプセル
・タブレット
・吸収性止血剤
・その他用途
※(市場規模US$)
◆原料由来別、市場-2027 年
・豚
・牛皮
・牛骨
・海洋生物
・家禽
※(市場規模US$)
◆機能別、市場-2027 年
・安定化剤
・増粘剤
・ゲル化剤/その他機能
※(市場規模US$)
◆タイプ別、市場-2027 年
・Bタイプ
・Aタイプ
※(市場規模US$)
◆主要国地域別市場-2027年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・価格分析
・バリューチェーン分析
・エコシステム分析
・技術分析
・ファイブフォース分析
・市場シェア分析
・競合状況
◆医薬品用ゼラチンの主要企業プロフィール動向
・DARLING INGREDIENTS
・新田ゼラチン株式会社
・TESSENDERLO GROUP
・GELITA AG
・WEISHARDT
・TROBAS GELATINE
・LAPI GELATINE
・INDIA GELATINE & CHEMICALS
・GELNEX
・JUNCA GELATINES
・HEBEI CHENGDA MINGJIAO
・ITALGEL
・XIAMEN GELKEN GELATIN
・GELCO INTERNATIONAL
・HENAN BOOM GELATIN
・NORLAND PRODUCTS
・GELIKO
・KENNEY & ROSS LIMITED
・BAOTOU DONGBAO BIO-TECH
・GELTEC
・NARMADA GELATINES.
・REINERT GRUPPE INGREDIENTS GMBH
・JELLICE GELATIN & COLLAGEN
・STERLING GELATIN
・ATHOS COLLAGEN
（全190頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1.... INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED.. 29
1.3.2 CURRENCY CONSIDERED
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2.... RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 1...................................................... RESEARCH DESIGN.. 32
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
・ FIGURE 2......... PHARMACEUTICAL GELATIN MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
・ FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)
・ FIGURE 4....................... AVERAGE MARKET SIZE ESTIMATION (2021)
2.3 DATA TRIANGULATION APPROACH
・ FIGURE 5.............................. DATA TRIANGULATION METHODOLOGY
2.4 GROWTH RATE ASSUMPTIONS
2.5 RISK ASSESSMENT
2.6 GROWTH FORECAST
2.6.1 SUPPLY-SIDE ANALYSIS
2.6.1.1 INSIGHTS FROM PRIMARY EXPERTS
3.... EXECUTIVE SUMMARY
・ FIGURE 6. PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
・ FIGURE 7.. PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2022 VS. 2027 (USD MILLION)
・ FIGURE 8... PHARMACEUTICAL GELATIN MARKET SHARE, BY FUNCTION, 2021
・ FIGURE 9... PHARMACEUTICAL GELATIN MARKET SHARE, BY TYPE, 2021
・ FIGURE 10. GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL GELATIN MARKET
4.... PREMIUM INSIGHTS
4.1 PHARMACEUTICAL GELATIN MARKET OVERVIEW
・ FIGURE 11........... VERSATILITY OF GELATIN IN PHARMACEUTICAL AND BIOMEDICAL APPLICATIONS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SHARE, BY APPLICATION (2021)
・ FIGURE 12 HARD CAPSULES ACCOUNTED FOR LARGEST SHARE IN 2021
4.3 PHARMACEUTICAL GELATIN MARKET SHARE, BY SOURCE, 2022 VS. 2027
・ FIGURE 13............. PORCINE GELATIN TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 PHARMACEUTICAL GELATIN MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 14.. CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5.... MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 15 PHARMACEUTICAL GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 ADVANTAGES AND PROPERTIES OF GELATIN
5.2.1.2 LAUNCH OF ADVANCED PHARMA GELATINS
5.2.1.3 INCREASING BIOMEDICAL APPLICATIONS OF GELATIN
5.2.2 RESTRAINTS
5.2.2.1 CULTURAL RESTRICTIONS IN CERTAIN REGIONS
5.2.2.2 SHIFT TOWARD NON-GELATIN CAPSULES
5.2.3 OPPORTUNITIES
5.2.3.1 DEMAND FOR PHARMA GELATIN IN DEVELOPING COUNTRIES
5.2.3.2 ADOPTION OF GELATIN IN VACCINES AND BIOMEDICAL APPLICATIONS
5.2.4 CHALLENGES
5.2.4.1 INSUFFICIENT RAW MATERIALS
5.2.4.2 INCREASING INCIDENCE OF ANIMAL-BORNE DISEASES
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
・ FIGURE 16........... REVENUE SHIFTS AND NEW REVENUE POCKETS FOR PHARMACEUTICAL GELATIN
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND
・ TABLE 1.... AVERAGE SELLING PRICE OF PHARMACEUTICAL GELATIN, BY REGION
5.4.2 INDICATIVE PRICING ANALYSIS, BY MARKET PLAYER
・ TABLE 2.......... XIAMEN GELKEN GELATIN: AVERAGE SELLING PRICE OF PHARMACEUTICAL GELATIN
・ TABLE 3............. HENAN BOOM GELATIN: AVERAGE SELLING PRICE OF PHARMACEUTICAL GELATIN
5.5 VALUE CHAIN ANALYSIS
・ FIGURE 17........... PHARMACEUTICAL GELATIN MARKET: VALUE CHAIN ANALYSIS
5.5.1 SOURCING OF RAW MATERIAL
5.5.2 COLLECTION AND TRANSPORT OF RAW MATERIAL
5.5.3 RAW MATERIAL PREPARATION AND PROCESSING
5.5.4 GELATIN PRODUCTION
5.6 ECOSYSTEM ANALYSIS
5.6.1 FARMING INPUT
5.6.2 FARMING
5.6.3 SLAUGHTERING
5.6.4 MANUFACTURING
5.6.5 SUPPLIERS/DISTRIBUTORS
5.6.6 END-PRODUCT MANUFACTURERS
・ FIGURE 18 PHARMACEUTICAL GELATIN MARKET: ECOSYSTEM ANALYSIS
5.6.7 ROLE IN ECOSYSTEM... 57
5.7 TECHNOLOGY ANALYSIS
・ TABLE 4.......... PHARMACEUTICAL GELATIN MARKET: TECHNOLOGICAL ADVANCEMENTS, 2019–2022
5.8 PATENT ANALYSIS
5.8.1 LIST OF MAJOR PATENTS
5.9 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 5.. PHARMACEUTICAL GELATIN MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.9.2 BARGAINING POWER OF SUPPLIERS
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 THREAT FROM SUBSTITUTES
5.9.5 THREAT FROM NEW ENTRANTS
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
・ FIGURE 19... INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PHARMACEUTICAL GELATIN
・ FIGURE 20....... KEY BUYING CRITERIA FOR PHARMACEUTICAL GELATIN AMONG END USERS
5.11 REGULATORY LANDSCAPE
5.11.1 NORTH AMERICA
5.11.2 EUROPE
5.11.3 ASIA PACIFIC
5.11.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 6... REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 TRADE ANALYSIS
5.12.1 US
5.12.2 INDIA
・ TABLE 7..... TOP IMPORTERS OF GELATIN FROM INDIA, BY VALUE, 2020-2021 (APR-NOV)
5.12.3 BRAZIL
5.12.4 OVERVIEW OF GELATIN TRADE/IMPEX, BY COUNTRY
5.13 KEY CONFERENCES & EVENTS IN 2022–2023
・ TABLE 8 PHARMACEUTICAL GELATIN MARKET: DETAILED LIST OF EVENTS AND CONFERENCES
6.... PHARMACEUTICAL GELATIN MARKET, BY APPLICATION
6.1 INTRODUCTION
・ TABLE 9. PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
6.2 HARD CAPSULES
6.2.1 ADVANTAGES OF GELATIN-BASED HARD CAPSULES TO PROPEL MARKET
・ TABLE 10................. TYPICAL HARD GELATIN CAPSULE COMPOSITION
・ TABLE 11................ DIMENSIONS (IN MILLIMETERS) AND VOLUME (IN MILLIMETERS) OF TWO-PIECE HARD CAPSULES
・ TABLE 12... PHARMACEUTICAL GELATIN MARKET FOR HARD CAPSULES, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 13... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR HARD CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 14...... EUROPE: PHARMACEUTICAL GELATIN MARKET FOR HARD CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION). 71
・ TABLE 15 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR HARD CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 SOFTGEL CAPSULES
6.3.1 RISING DEMAND FOR SOFTGEL CAPSULES IN PHARMA INDUSTRY TO DRIVE GROWTH
・ TABLE 16....... DIFFERENCES BETWEEN HARD CAPSULES AND SOFTGEL CAPSULES
・ TABLE 17.............. PHARMACEUTICAL GELATIN MARKET FOR SOFTGEL CAPSULES, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 18... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR SOFTGEL CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 19.. EUROPE: PHARMACEUTICAL GELATIN MARKET FOR SOFTGEL CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 20....... ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR SOFTGEL CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 ・ TABLETS
6.4.1 USE OF GELATIN AS BINDERS IN ・ TABLETS TO CONTRIBUTE TO SEGMENTAL GROWTH
・ TABLE 21 IN VITRO PROPERTIES OF ・ TABLETS WITH GELATIN AS BINDER (CONCENTRATIONS 2.0-8.0%)
・ TABLE 22 PHARMACEUTICAL GELATIN MARKET FOR ・ TABLETS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 23......... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR ・ TABLETS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 24......... EUROPE: PHARMACEUTICAL GELATIN MARKET FOR ・ TABLETS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 25... ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR ・ TABLETS, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 ABSORBABLE HEMOSTATS
6.5.1 INCREASED ADOPTION OF ABSORBABLE HEMOSTATS TO DRIVE MARKET
・ TABLE 26....... PHARMACEUTICAL GELATIN MARKET FOR ABSORBABLE HEMOSTATS, BY REGION, 2020–2027 (USD MILLION). 77
・ TABLE 27... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR ABSORBABLE HEMOSTATS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 28.............. EUROPE: PHARMACEUTICAL GELATIN MARKET FOR ABSORBABLE HEMOSTATS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 29....... ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR ABSORBABLE HEMOSTATS, BY COUNTRY, 2020–2027 (USD MILLION)
6.6 OTHER APPLICATIONS
・ TABLE 30................. PHARMACEUTICAL GELATIN MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 31... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION). 79
・ TABLE 32.... EUROPE: PHARMACEUTICAL GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 33....... ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.... PHARMACEUTICAL GELATIN MARKET, BY SOURCE
7.1 INTRODUCTION
・ TABLE 34.......... AMINO ACID COMPOSITION OF GELATINS, BY SOURCE
・ TABLE 35..... PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 36..... PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (KT)
7.2 PORCINE
7.2.1 LOWER MANUFACTURING COSTS OF PORCINE RAW MATERIALS TO PROPEL MARKET GROWTH
・ TABLE 37............... US: PORK EXPORTS IN USD MILLION (2017-2021)
・ TABLE 38... PORCINE PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 39........ NORTH AMERICA: PORCINE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 40... EUROPE: PORCINE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 41 ASIA PACIFIC: PORCINE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 BOVINE SKIN
7.3.1 INCREASING AVAILABILITY OF BOVINE SKIN TO BOOST GROWTH
・ TABLE 42.......... BOVINE SKIN PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 43... NORTH AMERICA: BOVINE SKIN PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 44. EUROPE: BOVINE SKIN PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 45....... ASIA PACIFIC: BOVINE SKIN PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 BOVINE BONE
7.4.1 ADVANTAGES OF BOVINE BONE LIKELY TO SUPPORT DEMAND GROWTH
・ TABLE 46......... BOVINE BONE PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 47.. NORTH AMERICA: BOVINE BONE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 48 EUROPE: BOVINE BONE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 49...... ASIA PACIFIC: BOVINE BONE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 MARINE
7.5.1 INCIDENCE OF ZOONOTIC DISEASES IN CATTLE AND PIGS TO DRIVE DEMAND FOR MARINE GELATIN
・ TABLE 50.... MARINE PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 51......... NORTH AMERICA: MARINE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 52.... EUROPE: MARINE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 53. ASIA PACIFIC: MARINE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 POULTRY
7.6.1 AVAILABILITY OF POULTRY AS A RAW MATERIAL TO BOOST UTILITY
・ TABLE 54... POULTRY PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 55........ NORTH AMERICA: POULTRY PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 56... EUROPE: POULTRY PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 57 ASIA PACIFIC: POULTRY PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.... PHARMACEUTICAL GELATIN MARKET, BY FUNCTION
8.1 INTRODUCTION
・ TABLE 58... PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
8.2 STABILIZING AGENTS
8.2.1 RISING VACCINE AND CAPSULE PRODUCTION TO DRIVE DEMAND FOR STABILIZING AGENTS
・ TABLE 59......... PHARMACEUTICAL GELATIN MARKET FOR STABILIZING AGENTS, BY REGION, 2020–2027 (USD MILLION). 96
・ TABLE 60... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR STABILIZING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION). 96
・ TABLE 61.............. EUROPE: PHARMACEUTICAL GELATIN MARKET FOR STABILIZING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 62....... ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR STABILIZING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 THICKENING AGENTS
8.3.1 GROWING USE OF GELATIN IN SYRUPS AND LIQUID DOSAGE FORMS TO DRIVE MARKET
・ TABLE 63......... PHARMACEUTICAL GELATIN MARKET FOR THICKENING AGENTS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 64... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR THICKENING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION). 98
・ TABLE 65.............. EUROPE: PHARMACEUTICAL GELATIN MARKET FOR THICKENING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 66....... ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR THICKENING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 GELLING AGENTS & OTHER FUNCTIONS
8.4.1 WIDE APPLICATIONS IN SOFTGEL CAPSULES AND HEMOSTATS TO BOOST DEMAND FOR GELLING AGENTS
・ TABLE 67. PHARMACEUTICAL GELATIN MARKET FOR GELLING AGENTS & OTHER FUNCTIONS, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 68... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR GELLING AGENTS & OTHER FUNCTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 69.. EUROPE: PHARMACEUTICAL GELATIN MARKET FOR GELLING AGENTS & OTHER FUNCTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 70....... ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR GELLING AGENTS & OTHER FUNCTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9.... PHARMACEUTICAL GELATIN MARKET, BY TYPE
9.1 INTRODUCTION
・ TABLE 71... PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
9.2 TYPE B GELATIN
9.2.1 INCREASED DEMAND FOR BOVINE-BASED GELATIN TO PROPEL MARKET GROWTH
・ TABLE 72.................. NUTRITIONAL COMPOSITION OF TYPE B GELATIN
・ TABLE 73...... TYPE B PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 74........... NORTH AMERICA: TYPE B PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 75...... EUROPE: TYPE B PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 76 ASIA PACIFIC: TYPE B PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 TYPE A GELATIN
9.3.1 COST-EFFECTIVENESS OF PROCESSING TYPE A GELATIN TO DRIVE GROWTH
・ TABLE 77.................. NUTRITIONAL COMPOSITION OF TYPE A GELATIN
・ TABLE 78....... TYPE A PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
・ TABLE 79 NORTH AMERICA: TYPE A PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 80...... EUROPE: TYPE A PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 81 ASIA PACIFIC: TYPE A PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10.. PHARMACEUTICAL GELATIN MARKET, BY REGION
10.1 INTRODUCTION
・ TABLE 82 PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
・ FIGURE 21....... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
・ TABLE 83.... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 84.... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 85.... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 86.... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 87.... NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 INCREASED PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 88... US: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 89 US: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 90....... US: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 91..... US: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 INCREASING DEMAND FOR BIOPHARMACEUTICALS TO SUPPORT GROWTH
・ TABLE 92............... CANADA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 93.. CANADA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 94 CANADA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 95....... CANADA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3 EUROPE
・ TABLE 96. EUROPE: PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 97............... EUROPE: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 98.. EUROPE: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 99 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 100...... EUROPE: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 RISING FOCUS AND INVESTMENT IN PHARMACEUTICAL R&D TO PROMOTE MARKET GROWTH
・ TABLE 101........... GERMANY: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 102........... GERMANY: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 103........... GERMANY: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 104... GERMANY: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 INVESTMENTS IN NOVEL DRUG DEVELOPMENT TO PROPEL DEMAND FOR PHARMACEUTICAL GELATIN
・ TABLE 105. UK: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 106........ UK: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 107..... UK: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 108... UK: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 INCREASED INVESTMENT IN PHARMACEUTICAL R&D TO DRIVE DEMAND FOR PHARMACEUTICAL GELATIN
・ TABLE 109............. FRANCE: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 110. FRANCE: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 111............. FRANCE: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 112...... FRANCE: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 PHARMA R&D AND INNOVATION EFFORTS TO BOOST GELATIN USAGE
・ TABLE 113................. ITALY: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 114..... ITALY: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 115.. ITALY: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 116 ITALY: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 GROWING PHARMA MANUFACTURING TO FUEL DEMAND FOR GELATIN
・ TABLE 117................ SPAIN: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 118... SPAIN: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 119. SPAIN: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 120 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
・ TABLE 121 ROE: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 122...... ROE: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 123.... ROE: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 124.. ROE: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
・ FIGURE 22............ ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
・ TABLE 125....... ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 126....... ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 127....... ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 128....... ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 129 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 INCREASING AGING POPULATION TO CREATE GROWTH OPPORTUNITIES
・ TABLE 130................ JAPAN: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 131... JAPAN: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 132. JAPAN: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 133........ JAPAN: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 LARGE POPULATION AND AVAILABILITY OF RAW MATERIALS TO CONTRIBUTE TO MARKET GROWTH IN CHINA
・ TABLE 134................ CHINA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 135... CHINA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 136. CHINA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 137........ CHINA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 BOOMING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
・ TABLE 138................. INDIA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 139.... INDIA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 140.. INDIA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 141 INDIA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
・ TABLE 142............. ROAPAC: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 143 ROAPAC: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 144............. ROAPAC: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 145...... ROAPAC: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 RISING DEMAND FOR PHARMA GELATIN IN LATIN AMERICA TO DRIVE MARKET GROWTH
・ TABLE 146............... LATAM: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 147... LATAM: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 148 LATAM: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 149........ LATAM: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 RISING ADOPTION OF GELATIN-BASED PHARMA PRODUCTS TO PROPEL GROWTH
・ TABLE 150 MEA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 151...... MEA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
・ TABLE 152... MEA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
・ TABLE 153. MEA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.. COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
・ FIGURE 23 PHARMACEUTICAL GELATIN MARKET: STRATEGIES ADOPTED
11.3 REVENUE ANALYSIS
・ FIGURE 24..... REVENUE ANALYSIS FOR KEY COMPANIES (2019–2021)
11.4 MARKET SHARE ANALYSIS
・ FIGURE 25... PHARMACEUTICAL GELATIN MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
・ TABLE 154.............. PHARMACEUTICAL GELATIN MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS.. 147
11.5.3 PERVASIVE PLAYERS.. 147
11.5.4 PARTICIPANTS
・ FIGURE 26 PHARMACEUTICAL GELATIN MARKET: COMPANY EVALUATION QUADRANT, 2021
11.6 COMPANY EVALUATION QUADRANT FOR SMES/START-UPS (2021)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS.. 149
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES.. 149
・ FIGURE 27 PHARMACEUTICAL GELATIN MARKET: COMPANY EVALUATION QUADRANT FOR SMES/START-UPS, 2021
11.7 COMPETITIVE BENCHMARKING
・ TABLE 155.................................... OVERALL COMPANY FOOTPRINT
・ TABLE 156................................... COMPANY PRODUCT FOOTPRINT
・ TABLE 157................................... COMPANY REGIONAL FOOTPRINT
11.8 COMPETITIVE SCENARIO AND TRENDS
・ TABLE 158 PHARMACEUTICAL GELATIN MARKET: PRODUCT LAUNCHES, JANUARY 2019–OCTOBER 2022
・ TABLE 159....... PHARMACEUTICAL GELATIN MARKET: DEALS, JANUARY 2019–OCTOBER 2022
・ TABLE 160.................... PHARMACEUTICAL GELATIN MARKET: OTHER DEVELOPMENTS, JANUARY 2019–OCTOBER 2022
12.. COMPANY PROFILES
12.1 KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
12.1.1 DARLING INGREDIENTS
・ TABLE 161.................. DARLING INGREDIENTS: BUSINESS OVERVIEW
・ FIGURE 28........ DARLING INGREDIENTS: COMPANY SNAPSHOT (2022)
12.1.2 NITTA GELATIN
・ TABLE 162............................. NITTA GELATIN: BUSINESS OVERVIEW
・ FIGURE 29................... NITTA GELATIN: COMPANY SNAPSHOT (2022)
12.1.3 TESSENDERLO GROUP.. 162
・ TABLE 163................... TESSENDERLO GROUP: BUSINESS OVERVIEW
・ FIGURE 30......... TESSENDERLO GROUP: COMPANY SNAPSHOT (2022)
12.1.4 GELITA AG
・ TABLE 164................................... GELITA AG: BUSINESS OVERVIEW
12.1.5 WEISHARDT
・ TABLE 165................................ WEISHARDT: BUSINESS OVERVIEW
12.1.6 TROBAS GELATINE. 169
・ TABLE 166........................ TROBAS GELATINE: BUSINESS OVERVIEW
12.1.7 LAPI GELATINE
・ TABLE 167...................... LAPI GELATINE S.P.A: BUSINESS OVERVIEW
12.1.8 INDIA GELATINE & CHEMICALS
・ TABLE 168........ INDIA GELATINE & CHEMICALS: BUSINESS OVERVIEW
・ FIGURE 31........ INDIA GELATINE & CHEMICALS: COMPANY SNAPSHOT (2022)
12.1.9 GELNEX
・ TABLE 169...................................... GELNEX: BUSINESS OVERVIEW
12.1.10 JUNCA GELATINES
・ TABLE 170......................... JUNCA GELATINES: BUSINESS OVERVIEW
12.1.11 HEBEI CHENGDA MINGJIAO
・ TABLE 171............. HEBEI CHENGDA MINGJIAO: BUSINESS OVERVIEW
12.1.12 ITALGEL
・ TABLE 172...................................... ITALGEL: BUSINESS OVERVIEW
12.1.13 XIAMEN GELKEN GELATIN
・ TABLE 173................ XIAMEN GELKEN GELATIN BUSINESS OVERVIEW
12.1.14 GELCO INTERNATIONAL
・ TABLE 174.................. GELCO INTERNATIONAL: BUSINESS OVERVIEW
12.1.15 HENAN BOOM GELATIN
・ TABLE 175.................. HENAN BOOM GELATIN: BUSINESS OVERVIEW
12.1.16 NORLAND PRODUCTS
・ TABLE 176.................... NORLAND PRODUCTS: BUSINESS OVERVIEW
12.1.17 GELIKO
・ TABLE 177...................................... GELIKO: BUSINESS OVERVIEW
12.1.18 KENNEY & ROSS LIMITED
・ TABLE 178................ KENNEY & ROSS LIMITED: BUSINESS OVERVIEW
12.1.19 BAOTOU DONGBAO BIO-TECH
・ TABLE 179.......... BAOTOU DONGBAO BIO-TECH: BUSINESS OVERVIEW
12.1.20 GELTEC
・ TABLE 180...................................... GELTEC: BUSINESS OVERVIEW
12.1.21 NARMADA GELATINES.
・ TABLE 181.................... NARMADA GELATINES: BUSINESS OVERVIEW
・ FIGURE 32.......... NARMADA GELATINES: COMPANY SNAPSHOT (2022)
12.1.22 REINERT GRUPPE INGREDIENTS GMBH
・ TABLE 182............ REINERT GRUPPE INGREDIENTS GMBH: BUSINESS OVERVIEW
12.1.23 JELLICE GELATIN & COLLAGEN
・ TABLE 183...... JELLICE GELATIN AND COLLAGEN: BUSINESS OVERVIEW
12.1.24 STERLING GELATIN
・ TABLE 184........................ STERLING GELATIN: BUSINESS OVERVIEW
12.1.25 ATHOS COLLAGEN
・ TABLE 185...... ATHOS COLLAGEN: BUSINESS OVERVIEW
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.